Arkansas 2023 Regular Session

Arkansas House Bill HB1481

Introduced
2/21/23  
Refer
2/22/23  
Report Pass
3/1/23  
Engrossed
3/6/23  
Refer
3/6/23  
Report Pass
3/14/23  
Enrolled
3/16/23  
Chaptered
3/21/23  

Caption

To Create The Healthcare Insurer Share The Savings Act; And To Create The Arkansas Pharmacy Benefits Manager Share The Savings Act.

Impact

The passage of HB1481 is expected to directly influence state healthcare laws by enhancing the transparency of pharma pricing and rebate negotiations. By mandating that enrollees benefit from discounts and rebates, the bill not only positions consumer interest at the forefront but also seeks to adjust the operational methodologies of healthcare insurers. This legislative action may lead to more competitive pricing structures while encouraging a greater accountability among pharmacy benefits managers and healthcare insurers regarding their rebate agreements.

Summary

House Bill 1481, known as the 'Healthcare Insurer Share the Savings Act', was introduced to require healthcare insurers and pharmacy benefits managers in Arkansas to pass on savings from drug rebates directly to consumers. The bill establishes a defined framework for calculating 'defined cost sharing' for enrollees, ensuring that the cost sharing for prescription drugs is reduced by the total amount of rebates received from manufacturers. This approach aims to alleviate some financial burdens on patients, making essential medicines more affordable.

Sentiment

Overall sentiment regarding HB1481 appears to be positive among proponents of healthcare reform and cost reduction. Supporters believe that the bill represents a significant stride toward patient-centered care, addressing high drug prices by ensuring that savings are visibly reflected at the point-of-sale. However, there might be concerns raised by insurance companies and pharmacy benefits managers who could perceive the mandated rebate sharing as a disruption to their existing contracts and profit models. Moreover, the confidentiality clauses relating to rebate amounts could stir debate about transparency and market fairness.

Contention

Notable points of contention surrounding HB1481 include discussions regarding how rebates are negotiated and the proprietary nature of pricing information. Critics may argue that the bill places undue burden on pharmacy benefits managers, while others might question the potential for unintended consequences in drug pricing. Furthermore, ensuring compliance from healthcare insurers and effectively monitoring the implementation of these rebates are challenges that the state will need to address to fully realize the bill's intended benefits.

Companion Bills

No companion bills found.

Similar Bills

LA HB1121

Authorizes certain healthcare entities to refuse to provide healthcare services under certain circumstances

RI H7030

Creates the healthcare worker platform act that requires platforms offering healthcare shifts to register with the Rhode Island department of health while exempting them from being classified as nursing service agencies.

RI H7941

Requires insurers to pay electronic claims for healthcare coverage within 14 calendar days of receipt. Permits healthcare providers to dispute claim denials within 60 days and empowers the secretary of EOHHS to establish penalties for violations.

AR HB1299

To Prohibit Healthcare Insurers From Exercising Recoupment For Payment Of Healthcare Services More Than One Year After The Payment For Healthcare Services Was Made.

AR HB1301

To Amend The Prior Authorization Transparency Act.

RI H8310

Amends the timelines related to healthcare provider credentialing.

MA H2364

Providing safeguards for home healthcare workers

MA S1632

Providing safeguards for home healthcare workers